Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2014 Aug 13;56(4):1012–1019. doi: 10.3109/10428194.2014.946023

Figure 2.

Figure 2

(A) Overall survival in patients with therapy-related and matched de novo acute myeloid leukemia by cytogenetic risk group. (B) Overall survival in patients with therapy-related and matched de novo myelodysplastic syndrome by cytogenetic risk group.